Business

Optimi Health Announces Canadian Retail and E-Commerce Distribution Agreement for Functional Mushroom Supplements, Appoints Chief Financial Officer to Board of Directors, The Canadian Business Journal

VANCOUVER, British Columbia, August 25, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or “Company”), based in Canada A company licensed by Health Canada to produce natural, scalable, accessible, psychedelic and functional mushrooms for transformative human experiences, Optimi Life’s nutritional supplement mushroom products are licensed in Canada by We are pleased to announce that we have signed three new retail and e-commerce distribution agreements.

The deals with Well.ca, Vitasave and Healthy Planet were signed less than six months after the company launched Optimi Life (www.optimilife.com) in February. This is a line of functional mushroom supplements that are revolutionizing the industry with formulas made from the highest quality fruit possible. Body mushroom for total body and mind optimization.

Well.ca: Well.ca is the premier whole food e-commerce platform, offering the complete line of Optimi functional supplements to Canadians nationwide.

Vitasave: Vancouver-based Vitasave is the first retailer to include Optimi in its product range. Two retail stores and an e-commerce platform allow consumers in both the Greater Vancouver area and nationwide to access his Optimi products along with other supplements in one location.

Healthy Planet: Healthy Planet has agreed to bring Optimi’s full line of mushroom supplements to its web-based sales platform. We look forward to proving our worth and moving to his 30+ retail stores in Ontario.

Optimi CEO Bill Ciprick said the deal will strengthen the company’s B2B distribution network and position the Optimi Life brand for expansion into international markets.

“Our goal is to meet the growing consumer demand for high-quality whole mushroom products, and that starts with expanding Optimi’s nationwide distribution infrastructure,” added Ciprick. “With the global functional mushroom market estimated to grow 9.5% annually over the next six years, we will aggressively position the Optimi Life brand across Canada and international markets.”

Darren Mahaffy, general manager of Optimi Life, attributes Optimi Life’s early distribution and revenue success to quality and marketability.

“A lot of work went into building the story for Optimi Life,” Mahaffy said. “Today’s success is the first step in clarifying our position as a producer of pure, high-quality mushroom ingredients designed for the curious and ever-evolving health-conscious consumer. ”

Election of directors

Optimi is also pleased to announce the appointment of Jacob Safaik to its Board of Directors. Safarik is our Chief Financial Officer and was instrumental in the founding of his Optimi in 2019. As a Chartered Accountant, Mr. Safarik brings over 13 years of international project finance, business development and quality assurance experience. Mr. Safarik is also Co-Founder and Chief Financial Officer of BC Green Pharmaceuticals Inc.

“We are delighted to welcome Jacob to the Optimi board of directors,” said JJ Wilson, co-founder and chairman of the board. “Jacob’s deep experience in global finance, business development and regulatory compliance will enable Optimi to grow its business and become the number one trusted and compassionate supplier of safe, natural, EU-GMP grade psilocybin and synthetic psychedelics. It is an invaluable asset for Optimi as we pursue our goals, all over the world.”

To request an interview or for more information, please contact:

PR for investors
Michael Kidd
Email: [email protected]
Phone: +1 (902) 880 6121
Web: www.optimihealth.ca

About Optimi

Optimi Health Corp. is a Canada-based company licensed by Health Canada to produce natural EU-GMP grade psilocybin and synthetic psychedelic substances, as well as functional mushrooms focused on the health and wellness market. We manufacture and supply. Purpose-built to manufacture scalable psychedelic formulations to transform the human experience, the company’s goal is to become the #1 trusted, compassionate supplier of safe medicines worldwide. That’s it. Optimi’s products are grown at his two facilities totaling 20,000 square feet in Princeton, British Columbia, making him the largest grower of psilocybin and his MDMA in North America.

Forward-Looking Statements

This news release contains forward-looking statements and forward-looking information within the meaning of the securities laws of Canada that relate to Optimi’s current expectations and views on future events (collectively, the “forward-looking statements”). is included. Statements expressing or involving expectations, beliefs, plans, objectives, assumptions, or arguments about future events or performance (not always, but using words or phrases such as “likely to result”) “anticipate”, “continue”, “expect”, “expect”, “believe”, “estimate”, “intend”, “plan”, “ forecasts, forecasts, strategize, objective, and forecasts) are not historical facts and may be forward-looking statements and may not reflect actual results or outcomes as such. may involve estimates, assumptions and uncertainties that may cause them to differ materially from those expressed in forward-looking statements. There is no assurance that these expectations will prove correct, and undue reliance should not be placed on the forward-looking statements contained in this news release. These statements are made only as of the date of this news release. Specifically, this news release states that we are conducting under our approved Health Canada Dealer License related to psilocybin, psilocin and other psychedelic substances, some of which are synthetically formulated. contains forward-looking statements regarding its proposed activities and Optimi’s plans. , focus and purpose.

Forward-looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties. Many of them are beyond Optimi’s control and actual results or events could differ materially from those disclosed or implied in such statements. Forward-Looking Statements. Such risks and uncertainties include the impact and progression of the COVID-19 pandemic and as described in the “Forward-Looking Statements” and “Risk Factors” sections of our Annual Information Form dated January 12, 2022. and other factors including, but not limited to: , and other Continuous Disclosure documents available in his Optimi profile at www.sedar.com. Optimi undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. As new factors emerge from time to time, Optimi may not predict all of them or assess the impact of each such factor, and may produce results that differ materially from those that include any factor or combination of factors. It is not possible to assess the extent to which it can be caused. Forward-Looking Statements.

Any forward-looking statements contained in this news release are qualified in their entirety by this cautionary statement.

Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/db8ece49-d8f9-4ae0-b94a-b620d28f84f0
https://www.globenewswire.com/NewsRoom/AttachmentNg/c5ddcdcb-28fc-4d80-be67-56aa5ca3cd7c
https://www.globenewswire.com/NewsRoom/AttachmentNg/f6d0df17-9b76-415a-92e1-cb6446945bc4


CBJ Newsmaker

Optimi Health Announces Canadian Retail and E-Commerce Distribution Agreement for Functional Mushroom Supplements, Appoints Chief Financial Officer to Board of Directors, The Canadian Business Journal

Source link Optimi Health Announces Canadian Retail and E-Commerce Distribution Agreement for Functional Mushroom Supplements, Appoints Chief Financial Officer to Board of Directors, The Canadian Business Journal

Related Articles

Back to top button